NewAmsterdam Pharma Company N.V. NAMS
Set alert
20.07 USD +0.51 +2.61%
As of Nov 3, 2:29 PM ET
19.59 Day range 20.46
19.13 52-week range 42.21
- YTD
- -42.79%
- 1 year
- -45.76%
- Open
- 19.74
- Prev close
- 19.56
- Mkt cap
- 2.40B
- Vol
- 1.48M
- Avg vol
- 1.49M
- EPS
- -2.16
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 19.59
- High
- 20.46
- Forward P/E
- -12.77
- Beta
- 0.14
- Short ratio
- 8.28
- Inst. own
- 116.88%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 22.86
- 200-d avg
- 29.80
- 1y target
- 49.92
Analyst view
Price target (mean) 49.92 +148.7% upside
Now 20.07
- Target (low)
- 38.01
- Target (mean)
- 49.92
- Target (high)
- 59.27
Ratings (0m) 16 15 buy · 1 hold · 0 sell
- Strong buy3
- Buy12
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 16
- 1 month ago 16
- 2 months ago 16
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.43569 | -0.541 – -0.288 | -0.53143 | +18.0% | 6.41M | +2013.8% | 13 |
| Next quarter | -0.39323 | -0.554 – -0.234 | -0.53267 | +26.2% | 13.42M | +49489.6% | 13 |
| Current year | -1.66 | -1.87 – -1.43 | -1.45 | -14.1% | 24.76M | +30.1% | 12 |
| Next year | -1.55 | -2.74 – 1.88 | -1.64 | +5.5% | 119.88M | +384.1% | 12 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 8, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 19, 2026 | Guggenheim | Maintained | Buy | Buy |
| Feb 18, 2026 | Needham | Maintained | Buy | Buy |
| Jan 21, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Dec 16, 2025 | Stifel | Maintained | Buy | Buy |
| Dec 2, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| Nov 6, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 5, 2025 | Needham | Maintained | Buy | Buy |
| Oct 17, 2025 | Citigroup | Maintained | Buy | Buy |
| Aug 25, 2025 | Wells Fargo | Initiated | — | Overweight |
| Aug 7, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 17, 2025 | Goldman Sachs | Initiated | — | Neutral |
| Jun 17, 2025 | Citigroup | Initiated | — | Buy |
| Jun 12, 2025 | Needham | Reiterated | Buy | Buy |
| Jun 10, 2025 | Stifel | Initiated | — | Buy |
| May 8, 2025 | Needham | Maintained | Buy | Buy |
| Apr 8, 2025 | Needham | Reiterated | Buy | Buy |
| Feb 27, 2025 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Feb 27, 2025 | Needham | Maintained | Buy | Buy |
| Jan 28, 2025 | RBC Capital | Reiterated | Outperform | Outperform |
| Jan 24, 2025 | RBC Capital | Reiterated | Outperform | Outperform |
| Jan 14, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 30, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Dec 11, 2024 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Dec 5, 2024 | Needham | Reiterated | Buy | Buy |
| Nov 21, 2024 | Needham | Reiterated | Buy | Buy |
| Nov 11, 2024 | Needham | Reiterated | Buy | Buy |